Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 2 |
2021 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Identifying advanced stage NSCLC patients who benefit from afatinib therapy using 18F-afatinib PET/CT imaging.
Lung Cancer. 2021 May;155:156-162. doi: 10.1016/j.lungcan.2021.03.016. Epub 2021 Mar 26.
Lung Cancer. 2021.
PMID: 33836373
Free article.
Quantification of [18F]afatinib using PET/CT in NSCLC patients: a feasibility study.
van de Stadt EA, Yaqub M, Lammertsma AA, Poot AJ, Schober PR, Schuit RC, Smit EF, Bahce I, Hendrikse NH.
van de Stadt EA, et al.
EJNMMI Res. 2020 Aug 17;10(1):97. doi: 10.1186/s13550-020-00684-4.
EJNMMI Res. 2020.
PMID: 32804306
Free PMC article.
Item in Clipboard
Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients.
Bartelink IH, van de Stadt EA, Leeuwerik AF, Thijssen VLJL, Hupsel JRI, van den Nieuwendijk JF, Bahce I, Yaqub M, Hendrikse NH.
Bartelink IH, et al. Among authors: van de stadt ea.
Pharmaceuticals (Basel). 2022 Jun 27;15(7):796. doi: 10.3390/ph15070796.
Pharmaceuticals (Basel). 2022.
PMID: 35890095
Free PMC article.
Item in Clipboard
Relationship between Biodistribution and Tracer Kinetics of 11C-Erlotinib, 18F-Afatinib and 11C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis in Advanced Stage Non-Small Cell Lung Cancer Patients.
van de Stadt EA, Yaqub M, Schuit RC, Bartelink IH, Leeuwerik AF, Schwarte LA, de Langen AJ, Hendrikse H, Bahce I.
van de Stadt EA, et al.
Diagnostics (Basel). 2022 Apr 1;12(4):883. doi: 10.3390/diagnostics12040883.
Diagnostics (Basel). 2022.
PMID: 35453931
Free PMC article.
Item in Clipboard
ABCG2- and ABCB1 Inhibition Using Supratherapeutic Doses of Erlotinib: Clinical Implications in the Treatment of Central Nervous System Metastases.
van de Stadt EA, Yaqub M, Bahce I, Hendrikse NH.
van de Stadt EA, et al.
J Nucl Med. 2020 Feb;61(2):305. doi: 10.2967/jnumed.119.235705. Epub 2019 Oct 4.
J Nucl Med. 2020.
PMID: 31586007
Free article.
No abstract available.
Item in Clipboard
Cite
Cite